TRIM28 (KAP1) Protein

📖 Wiki Page

protein1263 wordssynced 2026-04-02

TRIM28 (KAP1) Protein

<div class="infobox infobox-protein">
<div class="infobox-header">TRIM28 (KAP1) Protein</div>
<table class="infobox-content">
<tr><th colspan="2" class="section-head">Basic Information</th></tr>
<tr><td class="label">Protein Name</td><td class="value">Transcriptional Intermediary Factor 1 Beta (TIF1β)</td></tr>
<tr><td class="label">Gene</td><td class="value">[TRIM28](/genes/trim28)</td></tr>
<tr><td class="label">UniProt ID</td><td class="value"><a href="https://www.uniprot.org/uniprot/Q13263" target="_blank">Q13263</a></td></tr>
<tr><td class="label">PDB Structures</td><td class="value">2JSS, 2L3V, 4DT3, 5YJC</td></tr>
<tr><td class="label">Molecular Weight</td><td class="value">110 kDa (835 amino acids)</td></tr>
<tr><td class="label">Subcellular Localization</td><td class="value">Nucleus (predominantly), also in cytoplasm</td></tr>
<tr><td class="label">Protein Family</td><td class="value">TRIM family, transcriptional co-repressors</td></tr>
<tr><td class="label">Brain Expression</td><td class="value">High in hippocampus, cortex, cerebellum</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">21 edges</a></td>
</tr>
</table>
</div>

TRIM28 (KAP1) Protein

Overview

...

TRIM28 (KAP1) Protein

Overview

Mermaid diagram (expand to render)

TRIM28 (also known as KAP1 or TIF1beta) is a multi-domain transcriptional co-repressor protein that serves as a molecular scaffold for gene silencing complexes. Originally identified as a co-repressor for KRAB-domain zinc finger proteins, TRIM28 has evolved to be recognized as a central regulator of diverse transcriptional programs including embryonic development, DNA damage response, neuronal plasticity, and stress responses.

In the nervous system, TRIM28 plays critical roles in neural development, synaptic function, and neuronal survival. Dysregulation of TRIM28-mediated transcriptional control has been implicated in multiple neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS)[@trimkap2019].

Structure

TRIM28 contains several distinct functional domains:

N-Terminal RING Finger Domain

The RING finger (R = really interesting new gene) domain at the N-terminus possesses E3 ubiquitin ligase activity. This domain mediates ubiquitination of target proteins including histones and transcription factors, contributing to transcriptional repression.

Bromo-Adjacent Homology (BAH) Domain

The BAH domain serves as a protein-protein interaction module that recognizes modified histones, particularly methylated H3K9. This domain bridges the connection between TRIM28 and chromatin states.

Plant Homeodomain (PHD) Finger

The PHD finger functions as a "reader" of histone modifications, particularly H3K4me0, allowing TRIM28 to be recruited to repressed chromatin regions.

C-Terminal Transcriptional Repression Domain

The C-terminal region contains the transcriptional repression domain that recruits histone modifiers including SETDB1 (H3K9 methyltransferase), HDACs (histone deacetylases), and the NuRD complex.

Central Coiled-Coil Domain

The coiled-coil region mediates protein-protein interactions with KRAB-ZFPs and other co-factors.

Normal Function

Transcriptional Repression via KRAB-ZFP Pathway

TRIM28's primary function is as the master co-repressor for KRAB-domain zinc finger proteins (KRAB-ZFPs), which constitute the largest family of transcriptional repressors in mammals. Upon KRAB-ZFP binding to DNA, TRIM28 is recruited through interaction with the KRAB domain. TRIM28 then serves as a scaffold to assemble repressive complexes:

SETDB1 recruitment — histone H3K9 methyltransferase that establishes repressive H3K9me3 marks

HDAC recruitment — removes activating acetyl groups from histones

NuRD complex recruitment — provides ATP-dependent chromatin remodeling and histone deactivation

HP1 recruitment — heterochromatin protein 1 binds H3K9me3 to compact chromatin

DNA Damage Response

TRIM28 plays a crucial role in the DNA damage response (DDR), particularly in the repair of double-strand breaks:

Non-homologous end joining (NHEJ): TRIM28 is recruited to DNA damage sites where it promotes transcriptional repression of damage-responsive genes
Homologous recombination (HR): TRIM28 regulates BRCA1-mediated repair pathways
p53 regulation: TRIM28 interacts with p53 family members to modulate stress responses
Chromatin relaxation: Mediates chromatin changes necessary for repair machinery access

Neuronal Development and Synaptic Plasticity

In the developing and adult nervous system, TRIM28 regulates:

Neurogenesis: Controls expression of genes critical for neural progenitor cell differentiation
Synaptogenesis: Regulates synaptic protein expression and synapse formation
Long-term potentiation (LTP): Modulates gene expression required for synaptic strengthening
Memory formation: Involved in hippocampal gene expression programs underlying learning and memory
Neuronal survival: Controls anti-apoptotic and stress response genes

Epigenetic Programming

TRIM28 is essential for establishing and maintaining epigenetic states during:

Spermatogenesis and germ cell development
Pluripotency maintenance in embryonic stem cells
X-chromosome inactivation (in female cells)
Genomic imprinting

Role in Neurodegenerative Disease

Alzheimer's Disease

TRIM28 dysfunction contributes to AD pathogenesis through multiple mechanisms:

Amyloid Processing: TRIM28-mediated repression affects expression of genes involved in amyloid precursor protein (APP) processing and amyloid-beta (Aβ) production. Altered TRIM28 activity may dysregulate BACE1 and presenilin expression.

Tau Pathology: TRIM28 regulates tau phosphorylation and aggregation genes. In AD models, TRIM28 mislocalization correlates with tau pathology progression.

Synaptic Dysfunction: Given its role in synaptic plasticity, TRIM28 dysregulation contributes to synaptic gene expression changes observed in AD brains. This affects excitatory synaptic transmission and LTP.

Neuroinflammation: TRIM28 modulates glial cell activation and cytokine expression. Dysregulated TRIM28 may contribute to chronic neuroinflammation in AD.

DNA Repair Deficits: Neuronal DNA damage accumulates with age. Impaired TRIM28-mediated DNA repair pathways may contribute to neuronal vulnerability in AD.

Parkinson's Disease

Dopaminergic Neuron Survival: TRIM28 regulates survival pathways in dopaminergic neurons. Its dysfunction may contribute to the selective vulnerability of substantia nigra neurons in PD.

α-Synuclein Regulation: TRIM28 may regulate genes involved in α-synuclein expression and aggregation. Altered transcriptional control could contribute to Lewy body formation.

Mitochondrial Function: TRIM28 modulates expression of mitochondrial quality control genes. Its dysfunction may exacerbate mitochondrial dysfunction in PD.

LRRK2 Pathway: TRIM28 interacts with pathways involving LRRK2 (leucine-rich repeat kinase 2), one of the major PD genetic risk factors.

Amyotrophic Lateral Sclerosis (ALS)

TDP-43 Pathology: TRIM28 interacts with RNA-binding proteins including TDP-43 (encoded by TARDBP). Dysregulated TRIM28 may contribute to TDP-43 aggregation in ALS.
C9orf72 Expansion: The GGGGCC repeat expansion in C9orf72, the most common genetic cause of familial ALS, affects TRIM28-mediated transcriptional programs.
Stress Granules: TRIM28 associates with stress granules, which are disrupted in ALS.

Other Neurological Disorders

Intellectual Disability: TRIM28 mutations cause a rare neurodevelopmental disorder characterized by intellectual disability and facial dysmorphism
Autism Spectrum Disorders: Altered TRIM28 function affects genes implicated in ASD
Rett Syndrome: TRIM28 regulates MeCP2 target genes

Protein Interactions

TRIM28 interacts with numerous proteins relevant to neurodegeneration:

| Partner | Interaction Type | Relevance |
|---------|------------------|-----------|
| SETDB1 | Direct binding | H3K9me3 deposition, transcriptional repression |
| HDAC1/2 | Complex formation | Histone deacetylation |
| p53 family | Direct interaction | DNA damage response, apoptosis regulation |
| KRAB-ZFPs | Co-repressor | Gene silencing |
| BRCA1 | Direct binding | DNA repair |
| MeCP2 | Complex formation | Epigenetic regulation in neurons |
| TDP-43 | Direct interaction | RNA metabolism |
| REST | Co-factors | Neuronal gene repression |

Therapeutic Targeting

Targeting TRIM28-mediated pathways presents both opportunities and challenges:

Potential Therapeutic Approaches

Modulation of KRAB-ZFP Activity: Developing compounds that alter KRAB-ZFP/TRIM28 interactions could modulate disease-relevant gene expression

Histone Acetylation Modulators: HDAC inhibitors indirectly affect TRIM28-mediated repression

SETDB1 Inhibitors: Specific inhibitors could release repression of neuroprotective genes

DNA Damage Response Enhancers: Boosting TRIM28-mediated DNA repair could protect neurons

Challenges

TRIM28 has diverse functions, making selective targeting difficult
Complete inhibition would have widespread effects on gene regulation
The blood-brain barrier presents challenges for small molecule delivery
More research needed on cell-type specific effects

Research Directions

Development of brain-penetrant HDAC inhibitors
Gene therapy approaches targeting specific KRAB-ZFPs
Small molecules modulating TRIM28 post-translational modifications
Antisense oligonucleotides for gene-specific targeting

Cross-References

[TRIM28 Gene](/genes/trim28)
[SETDB1 Protein](/proteins/setdb1-protein) — H3K9 methyltransferase partner
[DNA Damage Response](/mechanisms/dna-damage-response)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
[Epigenetics in Neurodegeneration](/mechanisms/epigenetic-modifications-neurodegeneration)

Key Publications

[TRIM28/KAP1 in transcriptional regulation and neurological diseases (2019)](https://doi.org/10.1016/j.tins.2019.03.004)

[KAP1-mediated repression in neuronal development (2018)](https://doi.org/10.1016/j.neuro.2018.04.004)

[KAP1 - Master Coordinator of Distinct Transcriptional Pathways (2018)](https://doi.org/10.1016/j.tibs.2018.03.005)

[KAP1 in neurodegeneration and brain disease (2022)](https://doi.org/10.1007/s12035-022-02920-5)

External Links

[UniProt: TRIM28 (Q13263)](https://www.uniprot.org/uniprot/Q13263)
[RCSB PDB: TRIM28 Structures](https://www.rcsb.org/search?searchType=by_residue_sequence&query=TRIM28)
[Gene: TRIM28 (NCBI)](https://www.ncbi.nlm.nih.gov/gene/23081)
[PubMed: TRIM28 neuroscience](https://pubmed.ncbi.nlm.nih.gov/?term=TRIM28+KAP1+neurons+neurodegeneration)

References

iyengar2022, KAP1 in neurodegeneration and brain disease (2022) (2022) [1](https://doi.org/10.1007/s12035-022-02920-5)
jakobsson2018, KAP1 - Master Coordinator of Distinct Transcriptional Pathways (2018) (2018) [1](https://doi.org/10.1016/j.tibs.2018.03.005)
kapmediated2018, KAP1-mediated repression in neuronal development (2018) (2018) [1](https://doi.org/10.1016/j.neuro.2018.04.004)
trimkap2019, TRIM28/KAP1 in transcriptional regulation and neurological diseases (2019) (2019) [1](https://doi.org/10.1016/j.tins.2019.03.004)

Pathway Diagram

The following diagram shows the key molecular relationships involving TRIM28 (KAP1) Protein discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →